 Avinger Inc NASDAQ:AVGR received 510k clearance from the FDA for a new clinical indication for the Pantheris image-guided atherectomy system. The clearance allows the Company to directly market Pantheris for in-stent restenosis ISR in the lower extremity arteries. 